Stock listing

Hlb Co., Ltd.

Selected listing: 028300 · KRX · KRW · KR

Hlb Co., Ltd. (KRX:028300), Health Technology. Latest release Jan 30, 2026: Elevar Therapeutics' NDA Resubmission For Rivoceranib With Camrelizumab Accepted…

028300:KRXKRWKRUpdated October 2, 2026
Hlb Co., Ltd. logo
Ticker
KRX:028300
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
KRX
Currency
KRW

About Hlb Co., Ltd.

Hlb Co., Ltd. is a public company traded under the ticker 028300 on the Korean market. Hlb Co., Ltd. focuses on its core business operations and aims to deliver value to its shareholders.

Latest news from Hlb Co., Ltd.

Elevar Therapeutics' NDA Resubmission For Rivoceranib With Camrelizumab Accepted By FDA

January 30, 2026

All Hlb Co., Ltd. news →

Research Hlb Co., Ltd.

Hlb Co., Ltd. company profile

View the public company page for Hlb Co., Ltd. on 6ix.

Hlb Co., Ltd. news

Read company news and market updates connected to Hlb Co., Ltd..

Hlb Co., Ltd. investor events

Find investor webinars, events, and replay context for Hlb Co., Ltd..